Association of tumor washout rates and accumulation of technetium-99m- MIBI with expression of P-glycoprotein in lung cancer

Journal of Nuclear Medicine

Volumn 39, Issue 2, 1998, Pages 228-234

  Kostakoglu, Lale ^a,b   Kiratli, Pinar ^a   Ruacan, Şevket ^a   Hayran, Mutlu ^a   Emri, Salih ^a   Ergün, Eser L ^a   Bekdik, Coşkun F ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

MDR1 gene; Multidrug resistance; P glycoprotein; Technetium 99m sestamibi; Washout

Indexed keywords

EPITOPE; GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACCUMULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG CANCER; MALE; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 2642647849     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989;58:137-171.
2. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-269.
3. Siedler J. Genetic aspects of multidrug resistance. Cancer 1992;70:1799-1809.
4. Nielsen D, Skovsgaard T. P-glycoprotein as multidrug transporter:a critical review of current multidrug resistant cell lines. Biochim Biophys Acta 1992;1139:169-183.
5. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-1653.
6. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant Pgp with an organotechnetium complex. Cancer Res 1993;53:977-984.
7. Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994;35:510-515.
8. Baldini N, Scotlandi K, Barbanti-Brodano G, et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N Engl J Med 1995;333: 1380-1385.
9. Ross DD, Thompson BW, Ordonez JV, Joneckis CC. Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin content. Cytometry 1989;10:185-191.
10. Chan H, Thorner P, Haddad G, Ling V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990;8:689-704.
11. Kessel D, Beck WT, Kukuruga D, Schulz V. Characterization of multidrug resistance by fluorescent dyes. Cancer Res 1991;51:4665-4670.
12. Noonan KE, Beck WT, Holzmayer TA, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 1990;87:7160-7164.
13. Epstein J, Xiao H, Oba BK. P-glycoprotein expression in plasma cell myeloma is associated with resistance to VAD. Blood 1989;74:913-917.
14. Mae J-P, Zittoun R, Sikic BI. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlation with treatment outcome and in vitro drug sensitivity. Blood 1991;78:586-592.
15. Nooter K, Herweijer H. Multidrug resistance (mdr) genes in human cancer. Br J Cancer 1991;63:663-669.
16. Duran Cordobes M, Starzes A, Delmon-Moingeon L, et al. Technetium-99m uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996;37:286-289.
17. Kostakoglu L, Elahi N, Kiratli P, et al. Clinical validation of influence P-glycoprotein on the uptake of technetium-99m-sestamibi in patients with malignant tumors. J Nucl Med 1997:1003-1008.
18. Ramu A, Pollard HB, Rosario LM. Doxorubicin resistance in P388 leukemia-evidence for reduced drug influx. Int J Cancer 1989;44:539-547.
19. Deffie AM, Alam T, Seneviratne C, et al. Multifactorial resistance to Adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux and P-glycoprotein in cloned cell lines of Adriamycin-sensitive and resistant P388 leukemia. Cancer Res 1988;48:3595-3602.
20. Chin K-V, Pastan I, Gottesman MM. Function and regulation of the human multidrug resistance gene. Adv Cancer Res 1993;60:157-180.
21. Lai SL, Goldstein LJ, Gottesman MM, et al. MDR1 gene expression in lung cancer. J Natl Cancer Inst 1989;81:1144-1150.
22. Binaschi M, Supino R, Gambetta RA, et al. MRP gene overexpression in human doxorubicin-resistant SCLC cell line: alterations in cellular pharmacokinetics and in pattern of cross-resistance. Int J Cancer 1995;62:84-89.
23. Goldstein LJ, Gaski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:116-124.
24. Eijdems, De Haas M, Coco-Martin JM, et al. Mechanisms of MRP over-expression in four human lung-cancer cell lines and analysis of the MRP amplicon. Int J Cancer 1995;60:676-684.
25. Thomas GA, Barrand MA, Steward S, Rabbitts PH, Williams ED, Twentyman PR. Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumors and normal tissue as determined by in situ hybridisation. Eur J Cancer 1994;30A:1705-1709.
26. Giaccone G, van Ark Otte GJ, et al. MRP is frequently expressed in human lung cancer cell lines in non-small-cell lung cancer and in normal lungs. Int J Cancer 1996;66: 760-767.
27. Sugawara I, Yamada H, Nakamura H, et al. Preferential expression of the multidrug resistance-associated protein (MRP) in adenocarcinoma of the lung. Int J Cancer 1995;64:322-325.
28. Del Vecchio S, Stoppelli P, Carriero MV, et al. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 1993;53:3198-3206.
29. Li PY, Del Vecchio S, Fonti R, et al. Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. J Nucl Med 1996;37:665-672.